IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q1 2021 Results - Earnings Call Transcript
ImmunoGen, Inc. (IMGN) Q1 2021 Earnings Conference Call May 10, 2021, 08:00 AM ET Company Participants Courtney O'Konek - Senior Director, Corporate Communications and IR Mark Enyedy - President and CEO Anna Berkenblit - CMO Susan Altschuller - CFO Conference Call Participants John Newman - Cannacord Michael Schmidt - Guggenheim Boris Peaker - Cowen Luke Brennan - JPMorgan Andy Hsieh - William Blair Swayampakula Ramakanth - H.C. Wainwright Kennen MacKay - RBC Capital Markets Joe Catanzaro - Piper Sandler Kelly Shi - Jefferies Presentation Operator Good morning, and welcome to the ImmunoGen's First Quarter of 2021 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications and Investor Relations. Ma'am, please go ahead. Courtney O'Konek Good morning, and thank you for joining today's call. Earlier today, we issued a press release
For further details see:
ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q1 2021 Results - Earnings Call Transcript